These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15962454)

  • 1. Editorial comment: use of recombinant human growth hormone for wasting--questions for clinical practice.
    Wanke C
    AIDS Read; 2005 Jun; 15(6):309. PubMed ID: 15962454
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of recombinant human growth hormone on exercise capacity in patients with HIV-associated wasting on HAART.
    Evans WJ; Kotler DP; Staszewski S; Griffin GE; Isgaard J; Gertner JM; O'Brien F; Svanberg E
    AIDS Read; 2005 Jun; 15(6):301-3, 306-8, 310, 314. PubMed ID: 15962453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of bioelectrical impedance analysis to determine body composition changes in HIV-associated wasting.
    Klauke S; Fischer H; Rieger A; Frühauf L; Staszewski S; Althoff PH; Helm EB
    Int J STD AIDS; 2005 Apr; 16(4):307-13. PubMed ID: 15899085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy.
    Moyle GJ; Daar ES; Gertner JM; Kotler DP; Melchior JC; O'brien F; Svanberg E;
    J Acquir Immune Defic Syndr; 2004 Apr; 35(4):367-75. PubMed ID: 15097153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of HIV-associated wasting with recombinant human growth hormone: monitoring of body composition changes by bioelectrical impedance analysis (BIA).
    Jäger H; Knechten H; Moll A; Weitner L; Fischer H; Schmitt-Rau K
    Eur J Med Res; 2002 Mar; 7(3):103-8. PubMed ID: 11953280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated wasting in the era of HAART: a practice-based approach to diagnosis and treatment.
    Steinhart CR
    AIDS Read; 2001 Nov; 11(11):557-60, 566-9. PubMed ID: 11789018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release recombinant human growth hormone improves body composition and quality of life in adults with somatopause.
    Park JK; Hong JW; Kim CO; Kim SW; Lim CY; Chung YS; Kim SW; Lee EJ
    J Am Geriatr Soc; 2011 May; 59(5):944-7. PubMed ID: 21568970
    [No Abstract]   [Full Text] [Related]  

  • 9. Somatropin (mammalian cell-derived recombinant human growth hormone) for HIV-associated wasting.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Oct; 3(10):30-5. PubMed ID: 11364744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment: treatment of HIV-associated cognitive impairment--beyond HAART.
    Parsons TD; Robertson KR
    AIDS Read; 2005 Jun; 15(6):293. PubMed ID: 15962452
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA approves human growth hormone for wasting syndrome.
    AIDS Patient Care STDS; 1996 Dec; 10(6):379-80. PubMed ID: 11361571
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-term human growth hormone therapy for HIV-associated wasting.
    Nemechek PM
    AIDS Patient Care STDS; 1999 Jul; 13(7):391-3. PubMed ID: 10870592
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy.
    Bickel M; Zangos S; Jacobi V; Lutz T; Knecht G; Goebel F; Staszewski S; Klauke S
    HIV Med; 2006 Sep; 7(6):397-403. PubMed ID: 16903985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone does not affect viral load.
    AIDS Patient Care STDS; 2003 Nov; 17(11):610. PubMed ID: 14748361
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term effect on body composition and metabolic parameters after treatment with recombinant human growth hormone (r-hGH) in HIV-1 infected patients with lipodystrophy.
    Bickel M; Zangos S; Lutz T; Eisen J; Knecht G; Goebel FD; Crespi CM; Jacobi V; Staszewski S; Klauke S
    Scand J Infect Dis; 2008; 40(1):36-9. PubMed ID: 17852925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy for patients with HIV-hepatitis B virus coinfection.
    McGovern B
    Clin Infect Dis; 2007 Apr; 44(7):1012-3; author reply 1013. PubMed ID: 17342661
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-retroviral drug induced partial anterior interosseous nerve palsy: a case report.
    Unadkat J; Wollstein R
    J Plast Reconstr Aesthet Surg; 2009 Nov; 62(11):e540-1. PubMed ID: 18938121
    [No Abstract]   [Full Text] [Related]  

  • 18. Leprosy and HIV co-infection in five patients.
    Trindade MA; Manini MI; Masetti JH; Leite MA; Takahashi MD; Naafs B
    Lepr Rev; 2005 Jun; 76(2):162-6. PubMed ID: 16038250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptosporidiosis presenting as acute appendicitis: a case report.
    Buch K; Nguyen S; Divino CM; Weber K; Morotti RA
    Am Surg; 2005 Jun; 71(6):537-8. PubMed ID: 16044940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.